Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wölk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM.

Nature. 2007 Apr 12;446(7137):801-5. Epub 2007 Feb 25. Erratum in: Nature. 2007 Apr 12;446(7137):1 p following 805.

PMID:
17325668
2.

Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus.

Yang W, Qiu C, Biswas N, Jin J, Watkins SC, Montelaro RC, Coyne CB, Wang T.

J Biol Chem. 2008 Mar 28;283(13):8643-53. doi: 10.1074/jbc.M709824200. Epub 2008 Jan 22.

3.

Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.

Zheng A, Yuan F, Li Y, Zhu F, Hou P, Li J, Song X, Ding M, Deng H.

J Virol. 2007 Nov;81(22):12465-71. Epub 2007 Sep 5.

4.

A human claudin-1-derived peptide inhibits hepatitis C virus entry.

Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.

Hepatology. 2012 Aug;56(2):507-15. doi: 10.1002/hep.25685. Epub 2012 Jun 11.

5.

Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.

Haid S, Windisch MP, Bartenschlager R, Pietschmann T.

J Virol. 2010 Jan;84(2):964-75. doi: 10.1128/JVI.01504-09. Epub 2009 Nov 4.

6.

Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.

Riva L, Song OR, Prentoe J, Helle F, L'homme L, Gattolliat CH, Vandeputte A, Fénéant L, Belouzard S, Baumert TF, Asselah T, Bukh J, Brodin P, Cocquerel L, Rouillé Y, Dubuisson J.

J Virol. 2018 Apr 27;92(10). pii: e01982-17. doi: 10.1128/JVI.01982-17. Print 2018 May 15.

7.

Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.

Krieger SE, Zeisel MB, Davis C, Thumann C, Harris HJ, Schnober EK, Mee C, Soulier E, Royer C, Lambotin M, Grunert F, Dao Thi VL, Dreux M, Cosset FL, McKeating JA, Schuster C, Baumert TF.

Hepatology. 2010 Apr;51(4):1144-57. doi: 10.1002/hep.23445.

8.

Hepatitis C virus receptor expression in normal and diseased liver tissue.

Reynolds GM, Harris HJ, Jennings A, Hu K, Grove J, Lalor PF, Adams DH, Balfe P, Hübscher SG, McKeating JA.

Hepatology. 2008 Feb;47(2):418-27.

PMID:
18085708
9.

Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.

Mee CJ, Harris HJ, Farquhar MJ, Wilson G, Reynolds G, Davis C, van IJzendoorn SC, Balfe P, McKeating JA.

J Virol. 2009 Jun;83(12):6211-21. doi: 10.1128/JVI.00246-09. Epub 2009 Apr 8.

10.

CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.

Harris HJ, Farquhar MJ, Mee CJ, Davis C, Reynolds GM, Jennings A, Hu K, Yuan F, Deng H, Hubscher SG, Han JH, Balfe P, McKeating JA.

J Virol. 2008 May;82(10):5007-20. doi: 10.1128/JVI.02286-07. Epub 2008 Mar 12.

11.

Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.

Fukasawa M, Nagase S, Shirasago Y, Iida M, Yamashita M, Endo K, Yagi K, Suzuki T, Wakita T, Hanada K, Kuniyasu H, Kondoh M.

J Virol. 2015 May;89(9):4866-79. doi: 10.1128/JVI.03676-14. Epub 2015 Feb 11.

12.

The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.

Benedicto I, Molina-Jiménez F, Bartosch B, Cosset FL, Lavillette D, Prieto J, Moreno-Otero R, Valenzuela-Fernández A, Aldabe R, López-Cabrera M, Majano PL.

J Virol. 2009 Aug;83(16):8012-20. doi: 10.1128/JVI.00038-09. Epub 2009 Jun 10.

13.

Hepatitis C virus induces CD81 and claudin-1 endocytosis.

Farquhar MJ, Hu K, Harris HJ, Davis C, Brimacombe CL, Fletcher SJ, Baumert TF, Rappoport JZ, Balfe P, McKeating JA.

J Virol. 2012 Apr;86(8):4305-16. doi: 10.1128/JVI.06996-11. Epub 2012 Feb 8.

14.

Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.

Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T.

J Virol. 2009 Feb;83(4):2011-4. doi: 10.1128/JVI.01888-08. Epub 2008 Dec 3.

15.

Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.

Fofana I, Krieger SE, Grunert F, Glauben S, Xiao F, Fafi-Kremer S, Soulier E, Royer C, Thumann C, Mee CJ, McKeating JA, Dragic T, Pessaux P, Stoll-Keller F, Schuster C, Thompson J, Baumert TF.

Gastroenterology. 2010 Sep;139(3):953-64, 964.e1-4. doi: 10.1053/j.gastro.2010.05.073. Epub 2010 Jun 2.

16.

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM.

Nature. 2009 Feb 12;457(7231):882-6. doi: 10.1038/nature07684. Epub 2009 Jan 28.

17.
18.

Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell-cell contacts.

Cukierman L, Meertens L, Bertaux C, Kajumo F, Dragic T.

J Virol. 2009 Jun;83(11):5477-84. doi: 10.1128/JVI.02262-08. Epub 2009 Mar 18.

19.

Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.

Sekhar V, Pollicino T, Diaz G, Engle RE, Alayli F, Melis M, Kabat J, Tice A, Pomerenke A, Altan-Bonnet N, Zamboni F, Lusso P, Emerson SU, Farci P.

PLoS Pathog. 2018 Mar 14;14(3):e1006916. doi: 10.1371/journal.ppat.1006916. eCollection 2018 Mar.

20.

Effect of cell polarization on hepatitis C virus entry.

Mee CJ, Grove J, Harris HJ, Hu K, Balfe P, McKeating JA.

J Virol. 2008 Jan;82(1):461-70. Epub 2007 Oct 24.

Supplemental Content

Support Center